28 Aug Israeli cannabis firm aims to beat the pack with London listing
Israel’s Kanabo Research aims
this year to become the first cannabis company to list on
London’s main stock market, as part of efforts to raise 4
million pounds ($4.8 million) for clinical trials and to launch
over-the-counter products, its CEO said.
this year to become the first cannabis company to list on
London’s main stock market, as part of efforts to raise 4
million pounds ($4.8 million) for clinical trials and to launch
over-the-counter products, its CEO said.
Sorry, the comment form is closed at this time.